Newsletter Archive

51. 12.08.22 -- Regulatory Considerations Of Drug Abuse Potential Investigations 12/8/2022
    12/08/22 Clinical Leader Newsletter
52. 12.08.22 -- Advancing Pediatric Oncology Drug Development 12/8/2022

    12/08/22 Clinical Leader Newsletter

53. 12.08.22 -- Packaging And Outsourcing Partner Considerations 12/8/2022

    12/08/22 Clinical Leader Newsletter

54. 12.07.22 -- What Astellas Learned About Decentralized Trials 12/7/2022
    12/07/22 Clinical Leader Newsletter
55. 12.07.22 -- Clinical Trial Study Planning, Management, And Optimization 12/7/2022
    12/07/22 Clinical Leader Newsletter
56. 12.06.22 -- Clinical Trials Enter A New Digital Era 12/6/2022
    12/06/22 Clinical Leader Newsletter
57. 12.06.22 -- Empowering The Use Of eConsent 12/6/2022

    12/06/22 Clinical Leader Newsletter

58. 12.06.22 -- Tips For A Successful eConsent Process 12/6/2022

    12/06/22 Clinical Leader Newsletter

59. 12.05.22 -- 5 Ways To Expand Racial & Ethnic Diversity In Trials 12/5/2022
    12/05/22 Clinical Leader Newsletter
60. 12.05.22 -- Facilitating Good Clinical Data Review In Your Clinical Trial 12/5/2022
    12/05/22 Clinical Leader Newsletter